Biobest Group (now operating as BioFirst Group), a world leader in pollination and integrated biological control, has successfully issued its new USPP governed by Belgian law, which was subscribed by Pricoa Private Capital, a leading U.S. institutional investor.
This USD45 million private placement, with a 10-year maturity, was carried out on the basis of USPP documentation that is consistent with that used in the U.S. market, while being governed by Belgian law.
This transaction aims to finance the balance of the purchase price due by Biobest (BioFirst) for the acquisition of Biotrop Participações S.A. in Bazil.
For this transaction, the teams of CMS (France, Belgium and The Netherlands), Torys LLP (Canada) and FAS Advogados (CMS' cooperation partner in Brazil), coordinated by Marc-Etienne Sébire, Partner and Global Co-Head of the CMS Banking & Finance Group, comprised:
- CMS France: Marc-Etienne Sébire, partner, Myriam Issad and Pierre Maunand, associates; for capital markets matters.
- CMS Belgium: Benoît Vandervelde, partner, Anaïs Casteur, associate, for capital markets matters, and Arnout Vaninbroukx, counsel, for tax matters;
- CMS Netherlands: Etiënne Courbois, partner, Mathijs van der Veen and Camiel de Zoeten, associates;
- Torys LLP: Tom Zverina, partner, and Jacob Weinstock, associate; and
- FAS Advogados: Vicente Piccoli M. Braga, partner, Karine Oliveira and Ana Thereza M. Aguiar Vilela, associates.
Biobest (BioFirst) was advised by Jones Day, Willis Business Law and Stocche Forbes Advogados.
